Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37958846)

  • 1. Establishment and Comprehensive Molecular Characterization of an Immortalized Glioblastoma Cell Line from a Brazilian Patient.
    da Silva FF; Lupinacci FCS; Elias BDS; Beserra AO; Sanematsu P; Roffe M; Kulikowski LD; Costa FD; Santos TG; Hajj GNM
    Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of primary cilia in human glioblastoma.
    Sarkisian MR; Siebzehnrubl D; Hoang-Minh L; Deleyrolle L; Silver DJ; Siebzehnrubl FA; Guadiana SM; Srivinasan G; Semple-Rowland S; Harrison JK; Steindler DA; Reynolds BA
    J Neurooncol; 2014 Mar; 117(1):15-24. PubMed ID: 24510433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting βIII-tubulin in glioblastoma multiforme: from cell biology and histopathology to cancer therapeutics.
    Katsetos CD; Draber P; Kavallaris M
    Anticancer Agents Med Chem; 2011 Oct; 11(8):719-28. PubMed ID: 21707498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuronal markers are expressed in human gliomas and NSE knockdown sensitizes glioblastoma cells to radiotherapy and temozolomide.
    Yan T; Skaftnesmo KO; Leiss L; Sleire L; Wang J; Li X; Enger PØ
    BMC Cancer; 2011 Dec; 11():524. PubMed ID: 22185371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia-inducible factor-2α (HIF-2α), but not HIF-1α, is essential for hypoxic induction of class III β-tubulin expression in human glioblastoma cells.
    Bordji K; Grandval A; Cuhna-Alves L; Lechapt-Zalcman E; Bernaudin M
    FEBS J; 2014 Dec; 281(23):5220-36. PubMed ID: 25244496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel biphenyl diester derivative, AB38b, inhibits glioblastoma cell growth via the ROS-AKT/mTOR pathway.
    Meng Q; Zhou J; You F; Wu Y; Yang L; Wang Y; Zhang X; Gao S; Yu R; Yin X
    Biochem Pharmacol; 2021 Dec; 194():114795. PubMed ID: 34687671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrative analysis of cell adhesion molecules in glioblastoma identified prostaglandin F2 receptor inhibitor (PTGFRN) as an essential gene.
    Mala U; Baral TK; Somasundaram K
    BMC Cancer; 2022 Jun; 22(1):642. PubMed ID: 35690717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wild‑type IDH1 affects cell migration by modulating the PI3K/AKT/mTOR pathway in primary glioblastoma cells.
    Shen X; Wu S; Zhang J; Li M; Xu F; Wang A; Lei Y; Zhu G
    Mol Med Rep; 2020 Sep; 22(3):1949-1957. PubMed ID: 32705169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
    Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
    J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tubulin targets in the pathobiology and therapy of glioblastoma multiforme. I. Class III beta-tubulin.
    Katsetos CD; Dráberová E; Legido A; Dumontet C; Dráber P
    J Cell Physiol; 2009 Dec; 221(3):505-13. PubMed ID: 19650075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTP4A3 is a target for inhibition of cell proliferatin, migration and invasion through Akt/mTOR signaling pathway in glioblastoma under the regulation of miR-137.
    Wang L; Liu J; Zhong Z; Gong X; Liu W; Shi L; Li X
    Brain Res; 2016 Sep; 1646():441-450. PubMed ID: 27328425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and partial characterization of a new human glioblastoma cell line.
    Brehar FM; Bleotu C; Stefan LM; Buzgariu W; Chivu M; Utoiu E; Matei L; Ciurea AV; Tascu A
    Chirurgia (Bucur); 2009; 104(4):453-61. PubMed ID: 19886054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment and characteristics of GWH04, a new primary human glioblastoma cell line.
    Cheng F; Wan X; Wang B; Li Y; Peng P; Xu S; Han C; Mao F; Guo D
    Int J Oncol; 2022 Nov; 61(5):. PubMed ID: 36169178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EGF/EGFR upregulates and cooperates with Netrin-4 to protect glioblastoma cells from DNA damage-induced senescence.
    Li L; Huang Y; Gao Y; Shi T; Xu Y; Li H; Hyytiäinen M; Keski-Oja J; Jiang Q; Hu Y; Du Z
    BMC Cancer; 2018 Dec; 18(1):1215. PubMed ID: 30514230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progesterone at high doses reduces the growth of U87 and A172 glioblastoma cells: Proteomic changes regarding metabolism and immunity.
    Altinoz MA; Ucal Y; Yilmaz MC; Kiris İ; Ozisik O; Sezerman U; Ozpinar A; Elmaci İ
    Cancer Med; 2020 Aug; 9(16):5767-5780. PubMed ID: 32590878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-SEMA3A Antibody: A Novel Therapeutic Agent to Suppress Glioblastoma Tumor Growth.
    Lee J; Shin YJ; Lee K; Cho HJ; Sa JK; Lee SY; Kim SH; Lee J; Yoon Y; Nam DH
    Cancer Res Treat; 2018 Jul; 50(3):1009-1022. PubMed ID: 29129044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Notch- and vitamin D signaling in 1,25(OH)2D3-resistant glioblastoma multiforme (GBM) cell lines.
    Reichrath S; Müller CS; Gleissner B; Pfreundschuh M; Vogt T; Reichrath J
    J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):420-4. PubMed ID: 20206691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation regulates HEY1 expression in glioblastoma.
    Tsung AJ; Guda MR; Asuthkar S; Labak CM; Purvis IJ; Lu Y; Jain N; Bach SE; Prasad DVR; Velpula KK
    Oncotarget; 2017 Jul; 8(27):44398-44409. PubMed ID: 28574840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of programmed cell death 10 activates tumor cells and leads to temozolomide-resistance in glioblastoma.
    Nickel AC; Wan XY; Saban DV; Weng YL; Zhang S; Keyvani K; Sure U; Zhu Y
    J Neurooncol; 2019 Jan; 141(1):31-41. PubMed ID: 30392087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of TES by hypermethylation in glioblastoma reduces cell apoptosis and predicts poor clinical outcome.
    Bai Y; Zhang QG; Wang XH
    Eur J Med Res; 2014 Dec; 19(1):66. PubMed ID: 25498217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.